NIH #5R01CA269977-04
Unveiling non-coding drivers of cancer
- Amount
- $452K
- Period
- 2022-08-01 → 2027-07-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF CHICAGO
Cancer Genomics and Diagnostics · Cancer Research
9 total · 4 active
NIH #5R01CA269977-04
Awarded at UNIVERSITY OF CHICAGO
NIH #5R01CA269977-03
Awarded at UNIVERSITY OF CHICAGO
NIH #5R01CA269977-02
Awarded at UNIVERSITY OF CHICAGO
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
A Prognostic Signature for Lung Adenocarcinoma in Patients Who Have Never Smoked
Cancer Discovery · 2025-10-30
A prognostic signature for lung adenocarcinoma in people who have never smokedPreprint
bioRxiv (Cold Spring Harbor Laboratory) · 2025-08-16
Examining the Role of Extrachromosomal DNA in Lung CancerPreprint
bioRxiv (Cold Spring Harbor Laboratory) · 2025-06-07 · 5 citations
Cancer Research · 2025-04-25
Deciphering lung adenocarcinoma evolution and the role of LINE-1 retrotranspositionPreprint
bioRxiv (Cold Spring Harbor Laboratory) · 2025-03-16 · 6 citations
2024-12-02
2024-12-02
2024-12-02
Data from Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP InhibitorsPreprint
2024-12-02
2024-12-02
Nature Cancer · 2024-11-18 · 11 citations
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors
Clinical Cancer Research · 2024-09-25 · 17 citations
HYENA detects oncogenes activated by distal enhancers in cancer
Nucleic Acids Research · 2024-07-25 · 3 citations